for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Seegene Inc

096530.KQ

Latest Trade

114,400.00KRW

Change

4,700.00(+4.28%)

Volume

2,678,085

Today's Range

108,500.00

 - 

115,100.00

52 Week Range

19,050.00

 - 

141,400.00

As of on the KOSDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
109,700.00
Open
109,700.00
Volume
2,678,085
3M AVG Volume
131.56
Today's High
115,100.00
Today's Low
108,500.00
52 Week High
141,400.00
52 Week Low
19,050.00
Shares Out (MIL)
25.99
Market Cap (MIL)
2,877,872.00
Forward P/E
8.36
Dividend (Yield %)
0.09

Next Event

Q2 2020 Seegene Inc Earnings Release

Latest Developments

More

Cirrusdx Laboratory Receives Emergency Use Authorization From FDA For Covid-19 Testing

Eurobio Scientific Launches ALLPLEX CORONAVIRUS With Seegene

Seegene signs contract worth 7.75 bln won

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Seegene Inc

Seegene, Inc. is a Korea-based company engaged in the development, manufacturing and distribution of molecular diagnostic reagents. The Company mainly provides infectious pathogens inspection products, including allergic respiratory pathogens, sexually transmitted diseases pathogens, human papilloma virus (HPV) and other inspection products, drug resistance inspection products, single nucleotide polymorphisms (SNP) inspection products, as well as somatic mutation cancer inspection products. In addition, it is involved in the provision of automatic real-time detection instruments. The Company provides its products under the brand names of Seeplex, Anyplex and Magicplex. The Company distributes its products within domestic market and to overseas markets.

Industry

Biotechnology & Drugs

Contact Info

Taewon Bldg., 91, Ogeum-ro, Songpa-gu

05548

South Korea

+82.2.22404000

http://www.seegene.com/

Executive Leadership

Jong Yun Cheon

Chief Executive Officer, Director

Jong Gi Cheon

Vice President, Director

Hak Su Lee

Vice President, Director

David Dolinger

Vice President

Hae Jun Park

Managing Director

Key Stats

1.50 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, KRW)

2017

0.1K

2018

0.1K

2019

0.1K

2020(E)

0.8K
EPS (KRW)

2017

153.000

2018

378.000

2019

1,026.000

2020(E)

13,120.000
Price To Earnings (TTM)
51.54
Price To Sales (TTM)
16.33
Price To Book (MRQ)
15.51
Price To Cash Flow (TTM)
43.10
Total Debt To Equity (MRQ)
10.30
LT Debt To Equity (MRQ)
3.25
Return on Investment (TTM)
32.52
Return on Equity (TTM)
25.85

Latest News

Latest News

BRIEF-Seegene Exports 10 Million Corona Tests To Brazil

* SEEGENE INC - WILL EXPORT 10 MILLION TESTS OF ITS COVID-19 TESTING KITS TO PAN AMERICAN HEALTH ORGANIZATION / WHO THROUGH BRAZILIAN UNIT Source text for Eikon: Further company coverage:

BRIEF-Eurobio Scientific: CE Marking Of Seegene Coronavirus Test

* CE MARKING OF SEEGENE CORONAVIRUS TEST Source text for Eikon: Further company coverage: (Gdansk Newsroom)

BRIEF-Eurobio Scientific Launches ALLPLEX CORONAVIRUS With Seegene

* A FIRST TEST FROM THE PARTNER SEEGENE IS ALREADY MARKETED FOR RESEARCH LABORATORIES

BRIEF-Thermo Fisher Scientific Inc announced successful CE-IVD registration of its QuantStudio 5 Dx real-time PCR system for sale in European countries

* Thermo Fisher Scientific Inc - announced successful CE-IVD registration of its QuantStudio 5 Dx Real-Time PCR system for sale in European countries

BRIEF-Seegene signs contract worth 7.75 bln won

* Says it signed 7.75 billion won contract with Beckman Coulter Inc, to provide product

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up